New approaches for biomarker discovery in lung cancer

References

• Smith RA, Glynn TJ. Epidemiology of lung cancer. Racliol Clin. North Am. 38, 453–470 (2000).
   PubMedGoogle Scholar
• Jemal A, Thomas A, Murray T eta]. Cancer statistics. CA Cancerj Clin. 52,23–47 (2002).
   PubMed Web of Science ®Google Scholar
• •Latest cancer statistics.
   Google Scholar
• American Cancer Society, ACS, Facts & Figun-s 2002. American Cancer Society, Atlanta, GA, USA (2002).
   Google Scholar
• Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 86, 1867–1876 (1999).
   PubMed Web of Science ®Google Scholar
• Smith RA, Cokkinides V, Von Eschenbar A, et al American Cancer Society: guidelines for the early detection of cancer. CA Cancer 1 Clin. 52,8-22 (2002).
   Google Scholar
• Jett JR. Screening for lung cancer: no longer a taboo subject. J. Clin. Oncol 20, 1959–1961 (2002).
   PubMedGoogle Scholar
• Strauss GM. The Mayo lung cohort: a regression analysis focusing on lung cancer incidence and mortality. J. Clin. Oncol 20, 1973–1983 (2002).
   PubMedGoogle Scholar
• Haura EB. Treatment of advanced nonsmall-cell lung cancer: a review of current randomized clinical trials and an examination of emerging techniques. Cancer Control 8,326–336 (2001).
   PubMedGoogle Scholar
• Schiller JH. Current standards of care in small-cell and nonsmall-cell lung cancer. Oncology 61\(Suppl. 1), 3–13 (2001).
   Google Scholar
• •Chemotherapies cocktails for small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
   Google Scholar
• Mao L, Lee JS, Kurie JM, etal. Clonal genetic alterations in the lungs of current and former smokers' Natl. Cancer Inst. 89, 834–836 (1997).
   Google Scholar
• Witsuba II, Lam S, Behrens C, eta]. Molecular damages in the bronchial epithelium of current and former smokers. J. Nail Cancer Inst. 89,1966–1973(1997).
   Google Scholar
• •Comparative losss of heterozygosity (LOH) analysis in smokers and nonsmokers.
   Google Scholar
• Mulshine JL, Zhou J, Treston AM, Szabo E, Tockman MS, Cuttitta F. New approaches to the integrated management of early lung cancer. Hematol Oncol. Clin. North Am. 11, 235–252 (1997).
   PubMedGoogle Scholar
• Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y The new World Health Organization classification of lung tumours. FIR: Respir. J. 18,1059–1068 (2001).
   Google Scholar
• Carbone DP The biology of lung cancer. Semin. awl. 24,388–401 (1997).
   Google Scholar
• Tuveson TA, Jacks T Modeling human lung cancer in mice: similarities and shortcomings. Oncogene 18,5318–5324 (1999).
   PubMed Web of Science ®Google Scholar
• •Molecular analysis of lung cancer and relevance to the animal models.
   Google Scholar
• Thun MJ, Lally CA, Flannery JT eta]. Cigarette smoking and changes in the histopathology of lung cancer. J. Nall Cancer Inst. 89,1580–1586 (1997).
   PubMed Web of Science ®Google Scholar
• Salgia R, Skarin AT Molecular abnormalities in lung cancer. J. Clin. Onco1.16, 1207–1217 (1998).
   Google Scholar
• •Where to refresh roles and functions of oncogenes and tumor-suppressor genes relevant to lung cancer.
   Google Scholar
• Niklinski J, Niklinska W Chyczewski L, Becker HD, Pluygers E. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. Far. J. Cancer Prey 10,213–226 (2001).
   PubMedGoogle Scholar
• Braithwaite KL, Rabbitts PH. Multistep evolution of lung cancer. Semin. Cancer Biol. 9,255–265 (1999).
   PubMedGoogle Scholar
• Tockman MS. Lung cancer: chemoprevention and intermediate effect markers. IARC Sci. Publ. 154,257–270 (2001).
   PubMedGoogle Scholar
• Hirsch FR, Franklin WA, Gazdar AF, Bunn PA Jr. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin. Cancer Res. 7, 5–22 (2001).
   Google Scholar
• ••Clinical analysis of lung cancer pathologyand premalignant lesions.
   Google Scholar
• Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin. Oncol 29\(Suppl 4), 3–14 (2002).
   Google Scholar
• Gazdar AF, Minna JD. Molecular detection of early lung cancer. J. Nall Cancer Inst. 91, 299–301 (1999).
   PubMedGoogle Scholar
• Sidransky D. Molecular detection of lung cancer. In: Lung Cancer Cox, Hong (Eds). Blackwell Science, Oxford, UK, 253–268 (1998).
   Google Scholar
• Tockman MS, Mu1shine JL. The early detection of occult lung cancer. Chest Surg. Clin. North Am. 10,737-749 (2000).
   Google Scholar
• Tockman MS. Clinical detection of lung cancer progression markers. J. Cell Biochem. 25S, 177–184 (1996).
   Google Scholar
• Ahrendt SA, Chow JT, Xu LH, etal. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J. Nail Cancer Inst. 91,332–339 (1999).
   PubMed Web of Science ®Google Scholar
• Esteller M, Sanchez-Cespedes M, Rosen R, Sidranski D, Baylin SB, Herman JG. Detection of aberrant promoter hypermethylation of tumor-suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59,67–70 (1999).
   PubMed Web of Science ®Google Scholar
• Palmisano WA, Divine KK, Saccomanno G etal Predicting first-line lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 60,5954–5958 (2000).
   PubMed Web of Science ®Google Scholar
• Sozzi G, Musso K, Ratcliffe C, Goldstraw P, Pierotti MA, Pastorino U. Detection of microsatellite alterations in plasma DNA of nonsmall cell lung cancer patients: a prospect for early diagnosis. Clin. Cancer Res. 5,2689–2692 (1999).
   PubMed Web of Science ®Google Scholar
• Zhou J, Mulshine JL, Unsworth EJ et al Purification and characterization of a protein that permits early detection of lung cancer. J. Bid. Chem 271,10760–10766 (1996).
   PubMed Web of Science ®Google Scholar
• Tockman MS, Zhukhov TA, Erozan YS, et al. Antigen retrieval improves hnRNP A2/B1 immunohistochemical localization in premalignant lesions of the lung. In: Clinical and Biological Basis of Lung Cancer Prevention. Martinet Y, Hirsch FR, Martinet N, Vignaud J.-M, Mulshine JL (Eds) Birkhauser Verlag, Basel, Switzerland, 239–246 (1998) .
   Google Scholar
• Zhou J, Nong L, Wloch M, Zhukov TA, Tockman MS. Expression of early lung cancer detection marker hnRNP A2/B1 and its relation to microsatellite alteration in nonsmall cell lung cancer. Lung Cancer 34,342–350 (2001).
   Google Scholar
• Zhukov TA, Erozan YS,Tockman MS. Sentinel cell for lung cancer. Proceedings of the 14th International Congress of Cytology. Amsterdam, The Netherlands, 352, (2001).
   Google Scholar
• Man YG, Martinez A, Avis IM, etal. Phenotypically different cells with heterogenous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations. Am. J. Respir. Cell Md. Biol. 23,636-645 (2000).
   Google Scholar
• Tockman MS, Mulshine JL, Piantadosi S, etal Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res. 3, 2237— 2246 (1997).
   Google Scholar
• Fielding P, Tunbull L, Prime W etal Heterogenous nuclear ribonucleoprotein A2/B1 upregulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res. 5,4048–4052 (1999).
   PubMed Web of Science ®Google Scholar
• Sone S, Li F, Yang ZG et al. Results of three-year mass screening program for lung cancer using mobile low-dose spiral computed tomography scanner. Br. J. Cancer 84,25–32 (2001).
   PubMed Web of Science ®Google Scholar
• Henchke, CI, McCauley DI, Yankelevitz DF, etal Early lung cancer action project: overall design and fmdings from baseline screening. Lancet 354,99–105 (1999).
   PubMedGoogle Scholar
• Vazquez NE, Flieder DB. Small peripheral glandular lesions detected by screening CT for lung cancer. A diagnostic dilemma for the pathologist. Radiol Clin. North Am. 38,579–89, (2000).
   PubMedGoogle Scholar
• Swensen SJ, Jett JR, Sloan JA eta]. Screening for lung cancer with low-dose spiral computed tomography. Am. J. Resp. Grit. Care Med. 165,508–513 (2002).
   Google Scholar
• Lam S, Kennedy T, Unger M etal Localization of bronchial interepithelial neoplastic lesions by fluorescence bronchoscopy. Chest 113,696–702 (1998).
   PubMed Web of Science ®Google Scholar
• Strauss GM. Prognostic markers in resectable nonsmall cell lung cancer. Hematol. Oncol Clin. North Am. 11,409–434 (1997).
   PubMedGoogle Scholar
• Reinmuth N, Brandt B, Semik M eta]. Prognostic impact of CYFRA 21–1 and other serum markers in completely resected non-small cell lung cancer. Lung Cancer 3, 265–270 (2002).
   Google Scholar
• Ameral Mendes JJ, Pluygers B. Use of biochemical and molecular biomarkers for cancer risk assessment in humans. In: Perspectives on Biologically Based Cancer Risk Assessment. Cogliano VJ, Luebeck EG, Zapponi GA (Eds). Kluwer Academic / Plenum Publishers, NY, USA, 81–182 (2001).
   Google Scholar
• Liu MC, Gelmann ER P53 mutations: case study of a clinical marker for solid tumors. Semin. Oncol 29\(Suppl. 9), 246–257 (2002).
   Google Scholar
• Kern J, Schwartz D, Nordberg J etal pl 85' expression in human lung cancer adenocarcinomas predict short survival. Cancer Res. 50,5184–5191 (1990).
   PubMed Web of Science ®Google Scholar
• Hirsch FR, Franklin WA, Bunn PA Jr. Expression of target molecules in lung cancer: challenge for a new treatment paradigm. Semin. aka 29\(Suppl 9), 2–8 (2002).
   Google Scholar
• Schoemaker DD. Schadt EE, Armour CD eta]. Experimental annotation of the human genome using microarray technology. Nature 409,922–927 (2001).
   PubMed Web of Science ®Google Scholar
• Kallioniemi OR Biochip technologies in cancer research. Ann. Med. 33,142–147 (2001).
   Google Scholar
• •Review of DNA microarray applications in cancer.
   Google Scholar
• Young GD, Winokur TS, Cerfolio RJ etal Differential expression and biodistribution of cytokeratin 18 and desmoplakins in nonsmall cell lung carcinoma subtypes. Lung Cancer 36,133–141 (2002).
   PubMedGoogle Scholar
• Wang T, Fan L, Watanabe Y, McNeill P, Fanger GR, Persing DH, oral L5525, and alternatively spliced isoform of XAGE-1, is overexpressed in lung adenocarcinoma. Oncogene 20,7699–7709 (2001).
   PubMed Web of Science ®Google Scholar
• Beer D, Kardia S, Hanash S. Gene expression profiles predict survival of patients with lung adenocarcinoma. Nature Med. 8,816–824 (2002).
   Google Scholar
• Miura K, Bowman E, Simon R eta] Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco-smoking and prognosis-related molecular profiles. Cancer Res. 62, 3244–3250 (2002).
   PubMed Web of Science ®Google Scholar
• Simone NL, Bonner RF, Gillespie JVV, Emmert-Buck MR, Liotta LA. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. 7i-ends Genet. 14,272-76 (1998).
   Google Scholar
• Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Md. Cell Biol. 19, 1720–1730 (1999).
   Web of Science ®Google Scholar
• Chen G, Gharib TG, Huang CC, Taylor JM eta] Discordant protein and mRNA expression in lung adenocarcinomas. Md. Cell Prot. 4,304–213 (2002).
   Google Scholar
• Kapranov P, Cawley SE, Drenkow J, etal Large-scale transcriptional activity in chromosome 21 and 22. Science 296,916–919 (2002).
   PubMed Web of Science ®Google Scholar
• Maniatis T, Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418,236–243 (2002).
   PubMed Web of Science ®Google Scholar
• ••Good review.
   Google Scholar
• Rowen L, Young J, Birclitt B, etal. Analysis of the human neumxin genes: alternative splicing and the generation of protein diversity. Genomics9, 587–597 (2002).
   Google Scholar
• Hannon GJ. RNA interference. Nature 418,244–251 (2002).
   PubMed Web of Science ®Google Scholar
• ••Good review.
   Google Scholar
• Ahlquist P RNA-depenedent RNA polymerases, viruses, and RNA silencing. Science 296 1270–1273 (2002).
   PubMedGoogle Scholar
• ••Good review
   Google Scholar
• Lai EC. Micro RNAs are complementary to
   Google Scholar
• 'UTR sequence motifs that mediate negative post-transcriptional regulation. Nature Genet. 30,363-364 (2002).
   Google Scholar
• Mattick JS. Non coding RNAs: the architects of eukaryotic complexity. EMI30 Rep 2,986–991 (2001).
   Google Scholar
• Neubauer G, King A, Rappsilber J, et al Mass spectrometry and EST-database searching allows characterization of the multiprotein spliceosome complex. Nature Genet. 20,46–50 (1998).
   PubMed Web of Science ®Google Scholar
• Emmert-Buck MR, Gillespie JW, Paweletz CP, etal. An approach to proteomic analysis of human tumors. Moil Carcinog. 27,158–165 (2000).
   PubMed Web of Science ®Google Scholar
• Petricoin EF, Ardekani AM, Hitt BA etal. Use of proteomic patterns in serum to identify ovarian cancer Lancet 359,572–577 (2002).
   Google Scholar
• Petricoin EF, Ornstein DK, Paweletz CP et al. Serum proteomic patterns for detection of prostate cancer. J. Natl Cancer Inst. 94, 1576–1578 (2002).
   PubMed Web of Science ®Google Scholar
• Cazares LH, Adam BL, Ward MD etal. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ ionization mass spectrometry. Clin. Cancer Res. 8,2541–2552 (2002).
   Google Scholar
• Chen G, Gharib TG, Huang CC et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 7,2298–2305 (2002).
   Google Scholar
• Hanash S, Brichory F, Beer D. A proteomic approach to the identification of lung cancer markers. Dis. Markers 4,295–300 (2001).
   Google Scholar
• Oh JMC, Brichory F, Puravs E et al A database of protein expression in lung cancer. Proteomics 1, 1303–1319 (2001).
   PubMed Web of Science ®Google Scholar
• Zhukov TA, Johanson RA, Cantor AB, Clark RA, Tockman MS. Discovery of distinct profiles specific for lung tumors and premalignant lung lesions by SELDI mass spectrometry. Proceedings 93rd Annual AACR Meeting. CA, USA, 36 (2002).
   Google Scholar
• Adam BL, Vlahou A, Semmes OJ, Wright GL Jr. Proteomic approaches to biomarker discovery in prostate and bladder cancers. Proteomics 1, 1264–1270 (2001).
   Google Scholar
• Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA. Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev Drug Discov 1,683–695 (2002).
   Google Scholar
• •Good review.
   Google Scholar
• Valle RPC, Chavany C, Hernandez- Gonzalez R, Jendoubi M. Linking proteins to disease. Current Drug Discovety5, 35–39 (2002).
   Google Scholar
• •Review of ANTB3I0M1X approach.
   Google Scholar
• Marchetti A, Bertacca G, Buttitta F, eta]. Telomerase activity as a prognostic indicator in stage I NSCLC. Clin. Cancer Res. 5(8), 2077–2081 (1999).
   Google Scholar
• Proteomics Public-Private Group Maps Out Initiatives, (HUPO), Science News, Science 296,827 (2002).
   Google Scholar
• American Society of Clinical Oncology — lung cancer (Viewed December 2002) www.asco.org/ac/1,1003,_12-002138,00.asp
   Google Scholar
• •Published articles on various topics in lung cancer.
   Google Scholar
• American Society of Clinical Oncology - people living with cancer (Viewed December 2002) http://www.oncology.com/plwc/Home/ 1,1743„00.html
   Google Scholar
• •Detail information on all kinds of cancers — this link has details on lung cancer.
   Google Scholar
• American Cancer Society — lung cancer (Viewed December 2002) www.cancer.org/docroodhome/index.asp
   Google Scholar
• •Details on all kinds of cancers are given on this site. This link is for lung cancer. A good source for learning the basics.
   Google Scholar
• American Lung Association (Viewed December 2002) www.lungusa.org/
   Google Scholar
• •Focuses on asthma, tobacco control and environmental health, with news, reports, medical and legislative updates.
   Google Scholar
• National Cancer Institute (Viewed December 2002) www.cancer.govicancer_information/ cancer type/lung/
   Google Scholar
• •Details on all kinds of cancers are given on this site. This link is for lung cancer. A good source for learning the basics.
   Google Scholar
• Lung Cancer (Viewed December 2002) www.lungcancer.org/
   Google Scholar
• ••Charts and links are featured here relating to lung cancer and its connection to smoking.
   Google Scholar
• Medicine Online (Viewed December 2002) www.meds.com/lung/lunginfo.html
   Google Scholar
• ••The Lung Cancer Information Center is an electronic library of comprehensive educational materials on cancer for healthcare professionals and patients.
   Google Scholar